SMAD2/3 and NF-κB signaling support granulosa cell tumor (GCT) cell viability, and there is a positive feedback loop between NF-κB and SMAD3 signaling in late-stage GCT (101). The gene discussed is SMAD3; the disease is granular cell tumor.